HomeMarket NewsMicro Cap StocksNew CBD & THC Cannabis Oils Now Available in Australia from Canada

New CBD & THC Cannabis Oils Now Available in Australia from Canada

Actionable Trade Ideas

always free

kimzy nanney b2hacjfk cm unsplash13

MediPharm Labs Corp. LABS MEDIF MLZ announced that it has launched Canadian-produced GMP Beacon Medical cannabis oil and inhalation cartridges in the Australian medical marijuana market.

The newly available cannabis oil portfolio includes a high CBD Isolate (THC-free) oil, a balanced oil, and a THC dominant full spectrum oil made with Beacon’s popular medical flower strains.

In addition to the oil portfolio, the inhalation cartridges feature flavor-forward options that have been popular among Canadian patients, as well as strain-specific full-spectrum cartridges that utilize flower varieties already favored by Beacon Medical patients.

With the availability of Beacon Medical’s Pink Kush and GSC products in flower, oil, and inhalation formats, physicians and patients now have three delivery methods to consume the same full spectrum strains.

Deliveries of inhalation cartridges to patients have already begun, and the cannabis oils are scheduled to ship from Canada this week, according to a press release by the Toronto-based company.

MediPharm holds an Australian GMP license from the Therapeutic Goods Administration (TGA), complemented by its GMP status from Health Canada (Drug Establishment License) and the US FDA.

In July 2023, the TGA revised import and medical cannabis regulations, now requiring all products to meet cGMP standards.

What’s Next for Beacon Medical

Beacon Medical Australia plans to educate physicians and collect feedback on these newly launched products. To accomplish this, the company has expanded its medical scientific liaison field team to assist in the process. This initiative will further facilitate MediPharm Labs’ access to the Australian medical cannabis market.

For more information on the Cannabis Capital Conference, existing subscribers can access the live event through our research platform. New users can gain instant access by signing up here.

MEDIF Price Action

At the time of writing on Wednesday morning, MediPharm’s shares were trading 0.2686% higher at $0.056 per share.

Related News

Photo: Courtesy of Kimzy Nanney on Unsplash

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.